Discover

IMMX
Immix Biopharma, Inc.
9.83
2 x 7.30
2 x 12.33
bid
ask
-
0.48
4.66%
2 @ 06:53 AM
9.83 +0.00 (0.00%)
Ytd87.95%
1y348.86%
9.60
day range
10.29
1.94
52 week range
11.61
Open10.15Prev Close10.31Low9.60High10.29Mkt Cap699.80M
Vol1.82MAvg Vol1.36MEPS-0.92P/EN/AForward P/E-3.96
Beta0.10Short Ratio2.94Inst. Own17.64%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1550-d Avg9.24200-d Avg6.611yr Est7.00

IMMX News

Immix Biopharma Analyst Bullish But Flags Safety, Adoption Questions
benzinga.com
Immix Biopharma Analyst Bullish But Flags Safety, Adoption Questions

BofA Securities initiates Immix Biopharma with Buy rating, citing NXC-201's potential in AL amyl

This Intuit Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
benzinga.com
This Intuit Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

Wall Street analysts updated ratings for CURB, INTU, ENGN. See their outlooks and targets at Benzing

This Talen Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
benzinga.com
This Talen Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts changed outlook on top Wall Street names. See all changes on our analyst ratings page. Chec

benzinga.com
B of A Securities Initiates Coverage On Immix Biopharma with Buy Rating, Announces Price Target of $

B of A Securities analyst Tazeen Ahmad initiates coverage on Immix Biopharma (NASDAQ:IMMX) with a

benzinga.com
HC Wainwright & Co. Maintains Buy on Immix Biopharma, Raises Price Target to $20

HC Wainwright & Co. analyst Robert Burns maintains Immix Biopharma (NASDAQ:IMMX) with a Buy a

What's Going On With Immix Biopharma Stock Thursday?
benzinga.com
What's Going On With Immix Biopharma Stock Thursday?

Immix Biopharma (IMMX) prices $150M public offering to fund its NXC-201 cell therapy into mid-2028.

benzinga.com
Immix Biopharma Prices Underwritten Registered Offering Of 16,778,524 Shares At $8.94 Per Share

The gross proceeds to Immix from the offering, before deducting the underwriting discounts, commissi

benzinga.com
Immix Biopharma Announces That All Four Relapsed/Refractory Al Amyloidosis MRDd-Negative Patients Pr

–    Of first 20 patients, all four MRD-negative patients have converted to complete response (CR)  

benzinga.com
HC Wainwright & Co. Reiterates Buy on Immix Biopharma, Maintains $15 Price Target

HC Wainwright & Co. analyst Robert Burns reiterates Immix Biopharma (NASDAQ:IMMX) with a Buy

benzinga.com
Mizuho Maintains Outperform on Immix Biopharma, Raises Price Target to $15

Mizuho analyst Graig Suvannavejh maintains Immix Biopharma (NASDAQ:IMMX) with a Outperform and ra

benzinga.com
Citizens Reiterates Market Outperform on Immix Biopharma, Maintains $23 Price Target

Citizens analyst Reni J. Benjamin reiterates Immix Biopharma (NASDAQ:IMMX) with a Market Outperfo

benzinga.com
HC Wainwright & Co. Maintains Buy on Immix Biopharma, Raises Price Target to $15

HC Wainwright & Co. analyst Robert Burns maintains Immix Biopharma (NASDAQ:IMMX) with a Buy a

benzinga.com
Immix Biopharma Q4 EPS $(0.28) Misses $(0.16) Estimate

Immix Biopharma (NASDAQ:IMMX) reported quarterly losses of $(0.28) per share which missed the analys

benzinga.com
Morgan Stanley Initiates Coverage On Immix Biopharma with Overweight Rating, Announces Price Target

Morgan Stanley analyst Judah Frommer initiates coverage on Immix Biopharma (NASDAQ:IMMX) with a O

This Valaris Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
benzinga.com
This Valaris Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Wall Street analysts make changes to top stocks. Check our analyst ratings page for all updates. VAL

This Truist Financial Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
benzinga.com
This Truist Financial Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

Wall Street analysts upgraded and initiated coverage on top stocks, including Redwire, Zions Bancorp

This Aktis Oncology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
benzinga.com
This Aktis Oncology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top analysts change outlook on top names. See all analyst rating changes on Benzinga's analyst r

benzinga.com
Citizens Initiates Coverage On Immix Biopharma with Market Outperform Rating, Announces Price Target

Citizens analyst Reni Benjamin initiates coverage on Immix Biopharma (NASDAQ:IMMX) with a Market

benzinga.com
Mizuho Initiates Coverage On Immix Biopharma with Outperform Rating, Announces Price Target of $14

Mizuho analyst Graig Suvannavejh initiates coverage on Immix Biopharma (NASDAQ:IMMX) with a Outpe

benzinga.com
Immix Biopharma Granted Breakthrough Therapy Designation From FDA To NXC-201 To Treat Relapsed/Refra

Immix Biopharma, Inc. ("ImmixBio", "Company", "We" or "Us" or "I

Immix Biopharma (IMMX) Shares Slip As Investors Focus On Plans To Offer And Sell $750 Million In Securities
benzinga.com
Immix Biopharma (IMMX) Shares Slip As Investors Focus On Plans To Offer And Sell $750 Million In Sec

Immix Biopharma Inc (NASDAQ: IMMX) shares are trading lower Monday after the company filed a new she

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

benzinga.com
Market-Moving News for May 23rd

OKLO: 24% | Shares of OKLO and nuclear-linked stocks are trading higher amid report that President T

benzinga.com
Why Intuit Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 283 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  On Monday, 160 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  Friday's session saw 236 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 85 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 111 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 53 companies reached new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 120 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  During Tuesday's session, 78 companies made new 52-week lows.

benzinga.com
121 Stocks That Hit Their 52-Week Low

New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 12

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  During Wednesday's trading, 517 companies set new 52-week lows.

benzinga.com
77 Biggest Movers From Yesterday

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday afte

benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

 

benzinga.com
40 Stocks Moving In Tuesday's Mid-Day Session

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares jumped 360.8% to $9.86 after the company annou

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  Wednesday's session saw 784 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week

benzinga.com
Stocks That Hit 52-Week Lows On Monday

    On Monday, 721 companies achieved new lows for the year.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

    Tuesday's session saw 729 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

    On Friday, 368 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

    Wednesday's session saw 107 companies set new 52-week lows.